Exact Mass: 369.1760112
Exact Mass Matches: 369.1760112
Found 106 metabolites which its exact mass value is equals to given mass value 369.1760112,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Trimetrexate
C19H23N5O3 (369.18008080000004)
A nonclassical folic acid inhibitor through its inhibition of the enzyme dihydrofolate reductase. It is being tested for efficacy as an antineoplastic agent and as an antiparasitic agent against pneumocystis pneumonia in AIDS patients. Myelosuppression is its dose-limiting toxic effect. [PubChem] P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01A - Agents against amoebiasis and other protozoal diseases C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite C471 - Enzyme Inhibitor > C2153 - Dihydrofolate Reductase Inhibitor D004791 - Enzyme Inhibitors > D005493 - Folic Acid Antagonists D000890 - Anti-Infective Agents > D000935 - Antifungal Agents D009676 - Noxae > D000963 - Antimetabolites D000970 - Antineoplastic Agents Same as: D06238
Epanolol
C20H23N3O4 (369.16884780000004)
C - Cardiovascular system > C07 - Beta blocking agents > C07A - Beta blocking agents > C07AB - Beta blocking agents, selective C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Same as: D06646
Amisulpride
Amisulpride (trade name Solian) is an antipsychotic drug sold by Sanofi-Aventis. It is not approved for use in the United States, but is approved for use in Europe and Australia for the treatment of psychoses and schizophrenia. Additionally, it is approved in Italy for the treatment of dysthymia (under the brand name Deniban). Amisulpride is a selective dopamine antagonist. D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AL - Benzamides C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist Amisulpride is a dopamine D2/D3 receptor antagonist with Kis of 2.8 and 3.2 nM for human dopamine D2 and D3, respectively.
Jacoline
A pyrrolizine alkaloid obtained from senecionine by formal addition of hydrogen peroxide across the ethylidene double bond.
5-{[2-imino-4-(4-methoxybenzyl)-1-methyl-1,2-dihydro-1H-imidazol-5-yl]methyl}-2-methoxy-1,3-benzenediol|naamine C
C20H23N3O4 (369.16884780000004)
(12Xi,13Xi,14Xi,15Xi)-12,15,18-Trihydroxy-14-methyl-15,20-dihydro-21-nor-senecionan-11,16-dion|(12Xi,13Xi,14Xi,15Xi)-12,15,18-trihydroxy-14-methyl-15,20-dihydro-21-nor-senecionan-11,16-dione|12,15,18-trihydroxy-14xi-methyl-(12xiH,13xiH,15xiH)-15,20-dihydro-21-nor-senecionane-11,16-dione|Sceleratin
amisulpride
C17H27N3O4S (369.17221820000003)
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AL - Benzamides C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist CONFIDENCE standard compound; EAWAG_UCHEM_ID 2852 EAWAG_UCHEM_ID 2852; CONFIDENCE standard compound CONFIDENCE standard compound; INTERNAL_ID 2142 Amisulpride is a dopamine D2/D3 receptor antagonist with Kis of 2.8 and 3.2 nM for human dopamine D2 and D3, respectively.
ETHYL 6-AMINO-5-CYANO-2-METHYL-4-(4-MORPHOLINOPHENYL)-4H-PYRAN-3-CARBOXYLATE
C20H23N3O4 (369.16884780000004)
1-(4-AMINO-PHENYL)-AZETIDINE-3-CARBOXYLICACIDMETHYLESTER
C23H28ClNO (369.18593080000005)
6,7-bis(2-methoxyethoxy)-N-phenylquinazolin-4-amine
C20H23N3O4 (369.16884780000004)
Saxagliptin hydrochloride Monohydrate
C18H25N3O2.HCl.H2O (369.18190880000003)
(4-Cyclobutyl-1,4-diazepan-1-yl)(6-(4-fluorophenoxy)pyridin-3-yl)methanone
(15alpha,20R)-12,15,20-Trihydroxy-15,20-dihydrosenecionan-11,16-dione
2-Amino-1-[2-(4-morpholinyl)ethyl]-3-pyrrolo[3,2-b]quinoxalinecarboxylic acid ethyl ester
C19H23N5O3 (369.18008080000004)
L-Phenylalanine, L-phenylalanylglycyl-
C20H23N3O4 (369.16884780000004)
trimetrexate
C19H23N5O3 (369.18008080000004)
P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01A - Agents against amoebiasis and other protozoal diseases C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite C471 - Enzyme Inhibitor > C2153 - Dihydrofolate Reductase Inhibitor D004791 - Enzyme Inhibitors > D005493 - Folic Acid Antagonists D000890 - Anti-Infective Agents > D000935 - Antifungal Agents D009676 - Noxae > D000963 - Antimetabolites D000970 - Antineoplastic Agents Same as: D06238
Epanolol
C20H23N3O4 (369.16884780000004)
C - Cardiovascular system > C07 - Beta blocking agents > C07A - Beta blocking agents > C07AB - Beta blocking agents, selective C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Same as: D06646
Strictosidine aglycone(1+)
Conjugate acid of strictosidine aglycone arising from deprotonation of the secondary amino group; major species at pH 7.3.
3alpha-Sulfooxy-5alpha-androstan-17-one
C19H29O5S- (369.17356040000004)
2-[(2-acetamido-1-oxoethyl)amino]-N-(4-methoxyphenyl)-2-(4-methylphenyl)acetamide
C20H23N3O4 (369.16884780000004)
N-[4-({2-[(2,5-dimethylphenoxy)acetyl]hydrazino}carbonyl)phenyl]propanamide
C20H23N3O4 (369.16884780000004)
3,4,5-trimethoxy-N-[2-(1-methyl-2-benzimidazolyl)ethyl]benzamide
C20H23N3O4 (369.16884780000004)
3-Oxo-5alpha-androstan-17beta-yl sulfate
C19H29O5S- (369.17356040000004)
6-linalyl-2-O,3-dimethylflaviolin-7-olate
An organic anion that is the conjugate base of 6-linalyl-2-O,3-dimethylflaviolin, obtained by deprotonation of the 7-hydroxy group. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).
4-(9H-fluoren-9-yl)-N-phenyl-1-piperazinecarboxamide
3-nitro-4-(2-oxolanylmethylamino)-N-(2-phenylethyl)benzamide
C20H23N3O4 (369.16884780000004)
6,10-Dimethyl-N-(2-morpholin-4-ylethyl)-2-oxo-1,6,8-triazatricyclo[7.4.0.03,7]trideca-3(7),4,8,10,12-pentaene-5-carboxamide
C19H23N5O3 (369.18008080000004)
Hoerhammericine(1+)
An ammonium ion derivative resulting from the protonation of the tertiary amino group of hoerhammericine. The major species at pH 7.3. Note that the stereoconfiguration of the epoxy group is based on CHEBI:144374, and of the 19 hydroxy group on CHEBI:144372 (the same enzyme produces the two).
17-Oxo-5alpha-androstan-3beta-yl sulfate
C19H29O5S- (369.17356040000004)
1-[4-(difluoromethoxy)phenyl]-3-(4-methylphenyl)-6,7,8,9-tetrahydro-5H-imidazo[1,2-a]azepin-4-ium
C22H23F2N2O+ (369.17783519999995)
N-[[(2S,3S,4S)-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-3-phenyl-2-azetidinyl]methyl]-2-pyridinecarboxamide
C20H23N3O4 (369.16884780000004)
N-[[(2R,3R,4S)-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-3-phenyl-2-azetidinyl]methyl]-2-pyridinecarboxamide
C20H23N3O4 (369.16884780000004)
N-[[(2S,3R,4S)-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-3-phenyl-2-azetidinyl]methyl]-2-pyridinecarboxamide
C20H23N3O4 (369.16884780000004)
N-[[(2R,3S,4S)-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-3-phenyl-2-azetidinyl]methyl]-2-pyridinecarboxamide
C20H23N3O4 (369.16884780000004)
N-[[(2R,3S,4R)-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-3-phenyl-2-azetidinyl]methyl]-2-pyridinecarboxamide
C20H23N3O4 (369.16884780000004)
N-[[(2R,3R,4R)-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-3-phenyl-2-azetidinyl]methyl]-2-pyridinecarboxamide
C20H23N3O4 (369.16884780000004)
[(1R,5S)-7-[4-(3-methylphenyl)phenyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]-pyridin-4-ylmethanone
N-Ethyl-2,3,5,6-tetrahydro-4H,13H-15-oxa-3a,8-diaza-1H-dibenzo[a,hi]naphthacene-13-imine
5alpha-dihydrotestosterone sulfate(1-)
C19H29O5S (369.17356040000004)
A steroid sulfate oxoanion that is the conjugate base of 5alpha-dihydrotestosterone sulfate, obtained by deprotonation of the sulfo group; major species at pH 7.3.
androsterone sulfate(1-)
C19H29O5S (369.17356040000004)
A steroid sulfate oxoanion that is the conjugate base of androsterone sulfate, obtained by deprotonation of the sulfo group; major species at pH 7.3.
Gly-Phe-Phe
C20H23N3O4 (369.16884780000004)
A tripeptide composed of one glycine and two L-phenylalanine residues joined in sequence
epiandrosterone sulfate(1-)
C19H29O5S (369.17356040000004)
A steroid sulfate oxoanion that is the conjugate base of epiandrosterone sulfate, obtained by deprotonation of the sulfo group; major species at pH 7.3.
(S)-Amisulpride
C17H27N3O4S (369.17221820000003)
(S)-Amisulpride (Esamisulpride) is a potent dopamine D2/D3 receptor antagonist. (S)-Amisulpride is an antagonist at the 5-HT7 receptor with a KI of 900 nM. (S)-Amisulpride has antipsychotic and antidepressant effects[1][2].
Aramisulpride
C17H27N3O4S (369.17221820000003)
Aramisulpride is a dopamine D2 receptor and serotonin receptor antagonist used for the research of metabolic disorders[1].
MAGL-IN-1
C22H24FNO3 (369.17401259999997)
MAGL-IN-1 is a potent, selective, reversible and competitive inhibitor of MAGL, with an IC50 of 80 nM. MAGL-IN-1 exhibits anti-proliferative effects against human breast, colorectal, and ovarian cancer cells. MAGL-IN-1 blocks MAGL in cell-based as well as in vivo assays[1].
VU0357017 (hydrochloride)
C18H28ClN3O3 (369.1819088000001)
VU0357017 hydrochloride (CID-25010775) is a potent, selective and brain-penetrant allosteric agonist of M1 muscarinic acetylcholine receptor, with an EC50 of 477 nM. VU0357017 hydrochloride is highly selective for M1 and has no activity at M2-M5 up to the highest concentrations tested (30 μM). VU0357017 hydrochloride can be used for the research of Alzheimer’s disease and schizophrenia[1][2][3].
(1r,4r,5r,6r,16r)-5,6-dihydroxy-6-(hydroxymethyl)-4-isopropyl-5-methyl-2,8-dioxa-13-azatricyclo[8.5.1.0¹³,¹⁶]hexadec-10-ene-3,7-dione
5,6-dihydroxy-6-(1-hydroxyethyl)-4-isopropyl-2,8-dioxa-13-azatricyclo[8.5.1.0¹³,¹⁶]hexadec-10-ene-3,7-dione
(1r,4s,5r,6r,7r,17r)-4,7-dihydroxy-4-(hydroxymethyl)-5,6,7-trimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-ene-3,8-dione
5-({2-imino-1-[(4-methoxyphenyl)methyl]-3-methylimidazol-4-yl}methyl)-2-methoxybenzene-1,3-diol
C20H23N3O4 (369.16884780000004)
4,7-dihydroxy-7-(hydroxymethyl)-4,5,6-trimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-ene-3,8-dione
(1r,4s,5r,6r,7s,17r)-4,7-dihydroxy-7-(hydroxymethyl)-4,5,6-trimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-ene-3,8-dione
(3'as,6'r,6'ar)-3'a-hydroxy-2'-imino-6'a-methoxy-6'-(4-methoxyphenyl)-3'-methyl-4',6'-dihydro-1'h-spiro[cyclohexane-1,5'-cyclopenta[d]imidazole]-2,5-dien-4-one
C20H23N3O4 (369.16884780000004)
(1r,6s,17r)-4,7-dihydroxy-4-(hydroxymethyl)-5,6,7-trimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-ene-3,8-dione
(1r,7ar)-7-({[(2r,3s)-2,3-dihydroxy-2-(hydroxymethyl)butanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl 3-methylbut-2-enoate
(1r,4r,5s,6r,16r)-5,6-dihydroxy-6-[(1s)-1-hydroxyethyl]-4-isopropyl-2,8-dioxa-13-azatricyclo[8.5.1.0¹³,¹⁶]hexadec-10-ene-3,7-dione
(1s,4r,5r,6s,16r)-5,6-dihydroxy-6-[(1s)-1-hydroxyethyl]-4-isopropyl-2,8-dioxa-13-azatricyclo[8.5.1.0¹³,¹⁶]hexadec-10-ene-3,7-dione
(1r,4r,5r,6r,16r)-5,6-dihydroxy-6-[(1r)-1-hydroxyethyl]-4-isopropyl-2,8-dioxa-13-azatricyclo[8.5.1.0¹³,¹⁶]hexadec-10-ene-3,7-dione
(1s,4r,6s,7s,17r)-4,7-dihydroxy-4-[(1s)-1-hydroxyethyl]-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-ene-3,8-dione
(5r)-5-[(4-hydroxyphenyl)methyl]-2-imino-5-[(s)-methoxy(4-methoxyphenyl)methyl]-3-methylimidazolidin-4-one
C20H23N3O4 (369.16884780000004)
4,7-dihydroxy-4-(1-hydroxyethyl)-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-ene-3,8-dione
7-({[2,3-dihydroxy-2-(hydroxymethyl)butanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl 3-methylbut-2-enoate
4-hydroxy-n-[(3s,5r)-2-hydroxy-3-[(4-hydroxyphenyl)methyl]-3,4,5,6,7,8-hexahydro-1,4-diazocin-5-yl]benzamide
C20H23N3O4 (369.16884780000004)
4-ethylidene-7,12-dihydroxy-6,7-dimethyl-3,8-dioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadecan-14-ium-14-olate
6-(1h-indol-3-ylmethyl)-3-isopropyl-5-[(1e)-2-phenylethenyl]-1h-pyrazin-2-one
(1r,5r)-4,7-dihydroxy-7-(hydroxymethyl)-4,5,6-trimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-ene-3,8-dione
6-(1h-indol-3-ylmethyl)-3-isopropyl-5-[(1z)-2-phenylethenyl]-1h-pyrazin-2-one
(1r)-7-({[2,3-dihydroxy-2-(hydroxymethyl)butanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl (2z)-2-methylbut-2-enoate
(1r,4s,6r,7r,17r)-4,7-dihydroxy-4-[(1r)-1-hydroxyethyl]-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-ene-3,8-dione
(1r,4r,5s,6r,16s)-5,6-dihydroxy-6-[(1s)-1-hydroxyethyl]-4-isopropyl-2,8-dioxa-13-azatricyclo[8.5.1.0¹³,¹⁶]hexadec-10-ene-3,7-dione
5,6-dihydroxy-4-(2-hydroxypropan-2-yl)-5,6-dimethyl-2,8-dioxa-13-azatricyclo[8.5.1.0¹³,¹⁶]hexadec-10-ene-3,7-dione
2,15-dihydroxy-11-methoxy-14-methyl-9-(2-methylbut-3-en-2-yl)-2,13,16-triazatetracyclo[7.7.0.0¹,¹³.0³,⁸]hexadeca-3,5,7,10,15-pentaen-12-one
C20H23N3O4 (369.16884780000004)
(1s,9r,14s)-2,15-dihydroxy-11-methoxy-14-methyl-9-(2-methylbut-3-en-2-yl)-2,13,16-triazatetracyclo[7.7.0.0¹,¹³.0³,⁸]hexadeca-3,5,7,10,15-pentaen-12-one
C20H23N3O4 (369.16884780000004)
